Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 714-723

  Gordon, Shari N ^a,b   Kines, Rhonda C ^a   Kutsyna, Galyna ^a,b   Ma, Zhong Min ^c,d   Hryniewicz, Anna ^a,b   Roberts, Jeffery N ^a   Fenizia, Claudio ^a,b   Hidajat, Rachmat ^b   Brocca Cofano, Egidio ^b   Cuburu, Nicolas ^a   Buck, Christopher B ^a   Bernardo, Marcelino L ^e   Robert Guroff, Marjorie ^b   Miller, Christopher J ^c,d   Graham, Barney S ^f   Lowy, Douglas R ^a   Schiller, John T ^a   Franchini, Genoveffa ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAIC FREDERICK INC   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; MEDROXYPROGESTERONE ACETATE; PSEUDOVIRION; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 58; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREGULATION; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN VIRUS; STRUCTURAL GENE; T LYMPHOCYTE; VAGINA EPITHELIUM; VAGINA MUCOSA; VAGINA SECRETION; VIRAL GENE DELIVERY SYSTEM;

ALPHAPAPILLOMAVIRUS; ANIMALS; DNA, VIRAL; FEMALE; GENE PRODUCTS, GAG; GENE TRANSFER TECHNIQUES; HEK293 CELLS; HUMANS; IMMUNITY, MUCOSAL; LUMINESCENT PROTEINS; MACACA FASCICULARIS; MACACA MULATTA; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA; VIRION;

EID: 84863418996     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101404     Document Type: Article

References (37)

1. Wira, C. R., J. V. Fahey, C. L. Sentman, P. A. Pioli, and L. Shen. 2005. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol. Rev. 206: 306-335. (Pubitemid 41105178)
2. Wira, C. R., and J. V. Fahey. 2008. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 22: 1909-1917.
3. Padian, N. S., S. C. Shiboski, and N. P. Jewell. 1991. Female-to-male transmission of human immunodeficiency virus. JAMA 266: 1664-1667.
4. Buchbinder, S. P., D. V. Mehrotra, A. Duerr, D. W. Fitzgerald, R. Mogg, D. Li, P. B. Gilbert, J. R. Lama, M. Marmor, C. Del Rio, et al Step Study Protocol Team. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-ofconcept trial. Lancet 372: 1881-1893.
5. Rerks-Ngarm, S., P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal, J. Chiu, R. Paris, N. Premsri, C. Namwat, M. de Souza, E. Adams, et al MOPH-TAVEG Investigators. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361: 2209-2220.
6. Pitisuttithum, P., P. Gilbert, M. Gurwith, W. Heyward, M. Martin, F. van Griensven, D. Hu, J. W. Tappero, K. Choopanya; Bangkok Vaccine Evaluation Group. 2006. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J. Infect. Dis. 194: 1661-1671. (Pubitemid 44901996)
7. Hansen, S. G., C. Vieville, N. Whizin, L. Coyne-Johnson, D. C. Siess, D. D. Drummond, A. W. Legasse, M. K. Axthelm, K. Oswald, C. M. Trubey, et al. 2009. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 15: 293-299.
8. Hansen, S. G., J. C. Ford, M. S. Lewis, A. B. Ventura, C. M. Hughes, L. Coyne-Johnson, N. Whizin, K. Oswald, R. Shoemaker, T. Swanson, et al. 2011. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473: 523-527.
9. Schiller, J. T., P. M. Day, and R. C. Kines. 2010. Current understanding of the mechanism of HPV infection. Gynecol. Oncol. 118(1 Suppl): S12-S17.
10. Garland, S. M., M. Hernandez-Avila, C. M. Wheeler, G. Perez, D. M. Harper, S. Leodolter, G. W. Tang, D. G. Ferris, M. Steben, J. Bryan, et al; Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. 2007. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med. 356: 1928-1943. (Pubitemid 46740303)
11. Buck, C. B., D. V. Pastrana, D. R. Lowy, and J. T. Schiller. 2004. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 78: 751-757. (Pubitemid 38067597)
12. Buck, C. B., D. V. Pastrana, D. R. Lowy, and J. T. Schiller. 2005. Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol. Med. 119: 445-462.
13. Graham, B. S., R. C. Kines, K. S. Corbett, J. Nicewonger, T. R. Johnson, M. Chen, D. LaVigne, J. N. Roberts, N. Cuburu, J. T. Schiller, and C. B. Buck. 2010. Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination. Mucosal Immunol. 3: 475-486.
14. Roberts, J. N., C. B. Buck, C. D. Thompson, R. Kines, M. Bernardo, P. L. Choyke, D. R. Lowy, and J. T. Schiller. 2007. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 13: 857-861. (Pubitemid 47038188)
15. Roberts, J. N., R. C. Kines, H. Katki, D. R. Lowry, and J. T. Schiller. 2011. Effect of pap smear collection and carrageenan on cervicovaginal HPV16 infection in a rhesus macaque model. J. Natl. Cancer Inst. 103: 737-743.
16. Kines, R. C., C. D. Thompson, D. R. Lowy, J. T. Schiller, and P. M. Day. 2009. The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc. Natl. Acad. Sci. USA 106: 20458-20463.
17. Lenz, P., P. M. Day, Y. Y. Pang, S. A. Frye, P. N. Jensen, D. R. Lowy, and J. T. Schiller. 2001. Papillomavirus-like particles induce acute activation of dendritic cells. J. Immunol. 166: 5346-5355. (Pubitemid 32374153)
18. Rudolf, M. P., S. C. Fausch, D. M. Da Silva, and W. M. Kast. 2001. Human dendritic cells are activated by chimeric human papillomavirus type-16 viruslike particles and induce epitope-specific human T cell responses in vitro. J. Immunol. 166: 5917-5924. (Pubitemid 32440715)
19. Gordon, S. N., A. R. Weissman, V. Cecchinato, C. Fenizia, Z. M. Ma, T. H. Lee, L. Zaffiri, V. Andresen, R. W. Parks, K. S. Jones, et al. 2010. Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques. J. Virol. 84: 3043-3058.
20. Stevceva, L., B. Kelsall, J. Nacsa, M. Moniuszko, Z. Hel, E. Tryniszewska, and G. Franchini. 2002. Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251. J. Virol. 76: 9-18. (Pubitemid 33138987)
21. Romano, J. W., K. G. Williams, R. N. Shurtliff, C. Ginocchio, and M. Kaplan. 1997. NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics. Immunol. Invest. 26: 15-28. (Pubitemid 27066904)
22. Vaccari, M., J. Mattapallil, K. Song, W. P. Tsai, A. Hryniewicz, D. Venzon, M. Zanetti, K. A. Reimann, M. Roederer, and G. Franchini. 2008. Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency. J. Virol. 82: 9629-9638.
23. Pal, R., D. Venzon, N. L. Letvin, S. Santra, D. C. Montefiori, N. R. Miller, E. Tryniszewska, M. G. Lewis, T. C. VanCott, V. Hirsch, et al. 2002. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J. Virol. 76: 292-302. (Pubitemid 33139014)
24. Xiao, P., J. Zhao, L. J. Patterson, E. Brocca-Cofano, D. Venzon, P. A. Kozlowski, R. Hidajat, T. Demberg, and M. Robert-Guroff. 2010. Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J. Virol. 84: 7161-7173.
25. Niruthisard, S., R. E. Roddy, and S. Chutivongse. 1991. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex. Transm. Dis. 18: 176-179.
26. Patton, D. L., G. G. Kidder, Y. C. Sweeney, L. K. Rabe, and S. L. Hillier. 1999. Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). Am. J. Obstet. Gynecol. 180: 1080-1087. (Pubitemid 29258998)
27. Derdeyn, C. A., J. M. Decker, F. Bibollet-Ruche, J. L. Mokili, M. Muldoon, S. A. Denham, M. L. Heil, F. Kasolo, R. Musonda, B. H. Hahn, et al. 2004. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303: 2019-2022. (Pubitemid 38393277)
28. Keele, B. F., H. Li, G. H. Learn, P. Hraber, E. E. Giorgi, T. Grayson, C. Sun, Y. Chen, W. W. Yeh, N. L. Letvin, et al. 2009. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J. Exp. Med. 206: 1117-1134.
29. Stone, M., B. F. Keele, Z. M. Ma, E. Bailes, J. Dutra, B. H. Hahn, G. M. Shaw, and C. J. Miller. 2010. A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251. J. Virol. 84: 7083-7095.
30. Shi, W., J. Liu, Y. Huang, and L. Qiao. 2001. Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses. J. Virol. 75: 10139-10148. (Pubitemid 32948044)
31. Zhang, H., R. Fayad, X. Wang, D. Quinn, and L. Qiao. 2004. Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag. J. Virol. 78: 10249-10257. (Pubitemid 39258349)
32. Li, Z., S. Palaniyandi, R. Zeng, W. Tuo, D. C. Roopenian, and X. Zhu. 2011. Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc. Natl. Acad. Sci. USA 108: 4388-4393.
33. Lü, F. X. 2000. Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals. Clin. Immunol. 97: 59-68.
34. Bélec, L., T. Dupré, T. Prazuck, C. Tévi- Bénissan, J. M. Kanga, O. Pathey, X. S. Lu, and J. Pillot. 1995. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J. Infect. Dis. 172: 691-697.
35. Liu, J., B. F. Keele, H. Li, S. Keating, P. J. Norris, A. Carville, K. G. Mansfield, G. D. Tomaras, B. F. Haynes, D. Kolodkin-Gal, et al. 2010. Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys. J. Virol. 84: 10406-10412.
36. Wilkinson, D., M. Tholandi, G. Ramjee, and G. W. Rutherford. 2002. Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women. Lancet Infect. Dis. 2: 613-617.
37. Hel, Z., W. P. Tsai, E. Tryniszewska, J. Nacsa, P. D. Markham, M. G. Lewis, G. N. Pavlakis, B. K. Felber, J. Tartaglia, and G. Franchini. 2006. Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes. J. Immunol. 176: 85-96. (Pubitemid 43023252)